Media-OutReach Newswire AIM Vaccine has obtained clinical approval for two heavyweight products, creating new growth points for performance
Media-OutReach Newswire The global leader in rabies vaccines, the serum-free iterative rabies vaccine of AIM Vaccine has submitted a pre-application for marketing registration
Environment Hà Nội requires comprehensive emission data to develop effective air pollution control plan
Opinion US CDC work to help Việt Nam develop national CDC, get prepared for emerging health threats: Country Director
Media-OutReach Newswire AIM Vaccine’s 13-valent pneumonia conjugate vaccine obtained Production license
Media-OutReach Newswire The bull market of innovative drug technology is booming, and the leading stock AIM Vaccine has erupted upward